نتایج جستجو برای: hematopoietic stem cell transplantation

تعداد نتایج: 1898560  

آتشی, امیر, زمانی, هما, پرهیزکار, فاطمه, کاویانی جبلی, سعید,

Background and Objective: Mobilization of Hematopoietic Stem Cells (HSCs) for transplantation and the importance of -adrenergic signals in induction of this process have been well investigated. However, little is known about the role of -adrenergic signals in mobilization of HSCs and factors influenced by these signals. The Chemokine Stromal Derived Factor -1 (SDF-1) which is expressed by hum...

ژورنال: دانشور پزشکی 2017
بختیاری, مهرداد, تیموریان, شهرام, صادقی, مرتضی, ظفری, فریبا, مقانلو, احسان,

Background and Objective: Cell therapy is one of the attractive and novel approaches in the treatment of chronic wounds. The aim of this study was to evaluate the function of bone marrow derived hematopoietic stem cells (CD93) in the treatment of diabetic ulcers.   Materials and Methods: In this study, 15 BALB/c strain mice, weighing 25-30 g were used, of which 10 were made diabetic by s...

2015
Lisa Willemse Sheila Singh

• About Solid Tumours • Cancer Basics • Causes, risk factors and staging • Treatment • How are Stem Cells Helping in the battle against solid tumours? • History of hematopoietic stem cell transplantation (HSCT) • Autologous versus allogeneic HSCT • Allogeneic stem cell transplants – graft versus tumour effect • Autologous HSCT for solid tumours • Research and clinical directions • Hematopoietic...

Journal: :Blood 2003
Helene Roelofs Elmar S D de Pauw Aeilko H Zwinderman Sonja M Opdam Roel Willemze Hans J Tanke Willem E Fibbe

Hematopoietic reconstitution after stem cell transplantation requires excessive replicative activity because of the limited number of stem cells that are used for transplantation. Telomere shortening has been detected in hematopoietic cells after bone marrow transplantation. This has been thought to result from excessive replication of the stem cells, with putative concomitant reduction of thei...

Journal: :Journal of Bone Marrow Transplantation and Cellular Therapy 2023

In this 2022 Update of Version 2020 the VI Consensus Brazilian Society Bone Marrow Transplantation (SBTMO) for Graft-versus-Host-Disease (GVHD), we seek to provide evidence-based guidance on all novel and clinically relevant advancements in both prophylaxis therapy Graft-versus-Host Disease those who delve into field Hematopoietic Stem Cell Transplantation.

 Background and purpose: Several studies investigated the role of C-reactive protein (CRP) during transplantation and inflammation, and clinical outcomes after stem cell transplantation. In this study, we examined the relationship between the earliest CRP level on admission day, and the first outcome after transplantation, myeloid and platelet engraftment, and the length of hospitalization in p...

2017
Alişan Yıldıran Mehmet Halil Çeliksoy Stephan Borte Şükrü Nail Güner Murat Elli Tunç Fışgın Emel Özyürek Recep Sancak Gönül Oğur

Hematopoietic stem cell transplantation is a promising curative therapy for many combined primary immunodeficiencies and phagocytic disorders. We retrospectively reviewed pediatric cases of patients diagnosed with primary immunodeficiencies and scheduled for hematopoietic stem cell transplantation. We identified 22 patients (median age, 6 months; age range, 1 month to 10 years) with various dia...

2016
Luis F Porrata

In contrast to allogeneic hematopoietic stem cell transplantation, the current dogma is not an evidence of graft-versus-tumor effect in autologous hematopoietic stem cell transplantation; thus, it is assumed that autologous hematopoietic stem cell transplantation only relies on the high-dose chemotherapy to improve clinical outcomes. However, recent studies argue in favor of the existence of an...

Journal: :Cellular therapy and transplantation 2022

Ингибиторы тирозинкиназ: профилактика рецидива после аллогенной трансплантации гемопоэтических стволовых клеток у взрослых пациентов с Ph-позитивным острым лимфобластным лейкозомTyrosine kinase inhibitors: relapse prophylaxis after allogeneic hematopoietic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

2014
Mehmet Ali ERKURT Ilhami BERBER Irfan KUKU Emin KAYA Ilknur NIZAM

Allogeneic hematopoietic stem cell transplant is safe and curative treatment modality for many hematologic diseases. Expanding alternative donor options such as haploidentical hematopoietic stem cell transplantation and umbilical cord blood, taken together with enhanced outcomes of matched unrelated donors, has resulted in a advisable donor for most patients with an hematopoietic stem cell tran...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید